…a new quality guarantee for training providers in France.
The quality certification has been issued for the following category of action TRAINING ACTIVITIES.
This certification complies with the law of 5 September 2018 “for the freedom to choose one’s professional future”, which imposes mandatory certification according to a single national reference system. Training is a major stake for the quality assurance policies, particularly in the highly regulated sector of clinical research. It is also a key factor in maximising productivity. We provide an expert team to guide and train you.
Download our Qualiopi Certificate
to be independent in designing and configure an eCRF and/or in configuring the related administrative environment. These training courses firstly target data managers and project managers.
enables investigators, CRAs (Clinical Research Assistants), CSTs (Clinical Studies Technicians), etc., to use the software features in an autonomous way.
This training activity is registered under number 11 92 19676 92. It is part of continuous training actions according to the articles L 6313-1 to L 6313-11 of the French Employment Code. It provides financial assistance in the name of continuous professional training.
Number of training certificates issued :
132
Number of training
days completed :
32days
Overall trainee satisfaction rate :
97,2%
If you have any questions about our training program, please do not hesitate to contact our dedicated department by email at
formation-cleanweb@tentelemed.com
Download our rules of procedure
A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT
64 +
countries
involved
20 000 +
investigational
Centres
3 million +
patients
in database
50 000 +
users
worlwide
April 29, 2025
May 5 & 6 – Basel Telemedicine Technologies is pleased to present its CleanWeb™ eClinical suite, offering flexible, regulatory-compliant solutions tailored to every phase of clinical trials. Our platform includes a wide range of modules, such as eCRF, Randomization & Trial Supply Management, ePRO, eTMF, eConsent, Data Visualization, Vigilance, Imaging, CTMS, and more. We invite […]
April 29, 2025
Fierce Biotech The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. The data come from 20 pharmas that had the highest R&D budgets in 2020, as reported in Deloitte’s annual report, “Measuring the return from pharmaceutical innovation.” In 2024, the average […]
April 29, 2025
Biopharm International In January 2025, Samsung Biologics signed a six-year, $1.4 billion contract manufacturing agreement with an as-yet undisclosed European pharmaceutical company, with production to take place at Samsung’s manufacturing site in Songdo, South Korea (1). Simultaneously, at the J.P. Morgan Healthcare Conference held in San Francisco, the company announced plans to complete construction of […]